Draegerwerk AG & Co KGaA (ETR:DRW3) Given a €38.00 Price Target at Hauck & Aufhaeuser

Hauck & Aufhaeuser set a €38.00 ($44.19) price objective on Draegerwerk AG & Co KGaA (ETR:DRW3) in a research report report published on Wednesday, Borsen Zeitung reports. The brokerage currently has a neutral rating on the stock.

Other research analysts have also recently issued research reports about the company. Nord/LB set a €45.00 ($52.33) price objective on Draegerwerk AG & Co KGaA and gave the stock a neutral rating in a research note on Friday, April 26th. Deutsche Bank set a €46.00 ($53.49) price target on Draegerwerk AG & Co KGaA and gave the stock a neutral rating in a research note on Tuesday, April 30th. HSBC set a €44.00 ($51.16) price target on Draegerwerk AG & Co KGaA and gave the stock a neutral rating in a research note on Tuesday, April 16th. Independent Research set a €47.00 ($54.65) price target on Draegerwerk AG & Co KGaA and gave the stock a sell rating in a research note on Wednesday, July 17th. Finally, Warburg Research set a €49.00 ($56.98) price target on Draegerwerk AG & Co KGaA and gave the stock a neutral rating in a research note on Thursday, August 8th. Two equities research analysts have rated the stock with a sell rating and five have given a hold rating to the stock. The stock has a consensus rating of Hold and a consensus target price of €44.57 ($51.83).

Shares of Draegerwerk AG & Co KGaA stock traded down €0.86 ($1.00) during trading hours on Wednesday, reaching €39.12 ($45.49). The company’s stock had a trading volume of 12,576 shares, compared to its average volume of 33,804. The business has a fifty day simple moving average of €49.90. The stock has a market cap of $297.31 million and a P/E ratio of 15.81. Draegerwerk AG & Co KGaA has a one year low of €42.08 ($48.93) and a one year high of €73.00 ($84.88). The company has a quick ratio of 1.17, a current ratio of 1.98 and a debt-to-equity ratio of 20.16.



Draegerwerk AG & Co KGaA Company Profile

Drägerwerk AG & Co KGaA develops equipment and solutions in the fields of medical and safety technology in Europe, Americas, Africa, Asia, and Australia. The company develops, produces, and markets system solutions, equipment, and services for acute point of care, including emergency care, perioperative care, critical care, and perinatal care.

Featured Article: Why Invest in Dividend Achievers?

Analyst Recommendations for Draegerwerk AG & Co KGaA (ETR:DRW3)

Receive News & Ratings for Draegerwerk AG & Co KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Draegerwerk AG & Co KGaA and related companies with MarketBeat.com's FREE daily email newsletter.